Enabling Data Integrity from Drug Discovery through Manufacturing
White Paper Sep 19, 2018
When discussing the success of a drug therapy, a common topic amongst biopharmaceutical companies is data quality and data integrity; what the challenges are and what the key elements are to ensuring that the latest discovery is patentable, does not result in re-conducting critical research or development studies, is accepted by the regulators, or does not result in a recall of a batch of product.
A common challenge expressed amongst the industry is how to implement processes that promote and ensure that regulatory guidance’s are being followed and that their data is of the highest integrity.
High data quality and integrity is critical to ensure patient safety and drug efficacy from research and development through to manufacturing.
Related White Papers
4th international conference on Enzymology and molecular biology
May 10 - May 11, 2019
2nd AI Pharma Innovation: Drug Discovery 2019 Summit
Feb 27 - Feb 28, 2019
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019
14th World Congress on Medicinal Chemistry and Drug Design
Jun 10 - Jun 11, 2019